EN

Astrazeneca Plc Ordinary Shares(AZN)

Description

a pharmaceutical company that develops and launches innovative new drugs and pharmaceutical preparations

Key stats

Earnings

  1. US FDA DECISION DATE ON CAMIZESTRANT EXTENDED
  2. DATROWAY APPROVED IN US FOR 1L TRIPLE-NEGATIVE BC
  3. ENHERTU RECOMMENDED IN EU FOR HER2+ SOLID TUMOURS
  4. CAMIZESTRANT RECOMMENDED FOR BREAST CANCER IN EU